Breaking News Instant updates and real-time market news.

HMNY

Helios and Matheson

$0.02

0.0001 (0.58%)

10:33
10/15/18
10/15
10:33
10/15/18
10:33

Helios and Matheson: Proxy firms recommend voting for reverse stock split

Helios and Matheson Analytics announced that leading independent proxy advisory firms Institutional Shareholder Services Inc. and Glass, Lewis & Co., LLC have both recommended that Helios's stockholders vote "FOR" the proposed reverse stock split and the other proposal set forth in Helios's proxy statement for the upcoming special meeting of stockholders scheduled for October 18, 2018 at 10:00 a.m. local time. In its report, ISS stated, among other things, that: "A vote FOR [the proposal to approve the reverse stock split] is warranted given that the reverse stock split may enable Helios to maintain listing of its common stock on the Nasdaq Capital Market. Furthermore, the effective increase in the number of authorized shares would enable Helios to satisfy reserve requirements under certain convertible notes." Also, in its report, Glass Lewis stated, among other things, that: "We agree with the board that it is in the best interest of the Company to reduce the number of shares outstanding and thereby attempt to proportionally raise the per share price of the Company's common stock." Helios presented the reverse stock split proposal to regain compliance with the Nasdaq Capital Market $1.00 minimum bid price requirement. If the proposal is not approved, Helios believes that its common stock will be subject to delisting from the Nasdaq Capital Market, which would adversely impact the liquidity and marketability of its common stock. Commenting on the proxy advisors' recommendations, Theodore Farnsworth, CEO of Helios, stated: "The ISS and Glass Lewis recommendations are consistent with our view that maintaining Helios's listing on Nasdaq is in the best interests of Helios and its stockholders."

HMNY Helios and Matheson
$0.02

0.0001 (0.58%)

07/29/18
07/29/18
DOWNGRADE

Neutral
Helios and Matheson downgraded to Neutral from Buy at Euro Pacific
07/26/18
MAXM
07/26/18
INITIATION
MAXM
Hold
Helios and Matheson assumed with a Hold at Maxim
Maxim analyst Allen Klee assumed Helios and Matheson with a Hold rating, saying that while he remains optimistic about the potential for continued MoviePass subscriber growth, he is also cautious about the company's potential capital raising needs. Klee also sees the stock as a "high risk/reward" situation as it trades at 0.1-times his expected FY18 revenue estimate.
04/25/18
MAXM
04/25/18
INITIATION
Target $12
MAXM
Buy
Helios and Matheson assumed with a Buy at Maxim
Maxim analyst Nehal Chokshi assumed Helios and Matheson with a Buy rating but lowered his price target to $12 from $16 under the prior coverage. The analyst contends that survey findings suggest "overusage being contained to a sliver of subscribers" and believes the company can trade at $12 per share based on enterprise value of $1.4B is its MoviePass offering can show incremental traffic from occasional movie goers hitting just 1 movie ticket per month.
04/24/18
ADAM
04/24/18
NO CHANGE
Target $12
ADAM
Buy
Helios and Matheson price target lowered to $12 from $15 at Canaccord
Canaccord analyst Austin Moldow lowered his price target on Helios and Matheson to $12 from $15 following its recent capital raise. The analyst raised his revenue forecast, but it was more than offset by the higher share count given the company's capital raise and its at-the-market offering, where the company can sell shares in the open market at its discretion. Moldow maintained his Buy rating on Helios and Matheson shares.

TODAY'S FREE FLY STORIES

LOAN

Manhattan Bridge Capital

$6.37

0.02 (0.31%)

07:20
10/21/19
10/21
07:20
10/21/19
07:20
Earnings
Manhattan Bridge Capital reports Q3 EPS 12c, one est. 11c »

1Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VZ

Verizon

$61.05

0.64 (1.06%)

07:20
10/21/19
10/21
07:20
10/21/19
07:20
Periodicals
Verizon seeking buyer for HuffPost website, FT reports »

Verizon is seeking a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 25

    Oct

  • 26

    Oct

  • 19

    Nov

  • 09

    Dec

URGN

UroGen Pharma

$22.34

0.06 (0.27%)

07:20
10/21/19
10/21
07:20
10/21/19
07:20
Recommendations
UroGen Pharma analyst commentary  »

UroGen Pharma recent…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

07:20
10/21/19
10/21
07:20
10/21/19
07:20
General news
Treasury Market Outlook: yields are modestly higher as stocks rally »

Treasury Market Outlook:…

VLRX

Valeritas

$1.33

(0.00%)

07:18
10/21/19
10/21
07:18
10/21/19
07:18
Hot Stocks
Valeritas reports results from study on infusion of GLP-1 analogue with h-Patch »

Valeritas Holdings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FOMX

Foamix

$3.16

-0.08 (-2.47%)

07:17
10/21/19
10/21
07:17
10/21/19
07:17
Recommendations
Foamix analyst commentary  »

Foamix price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BA

Boeing

$344.09

-25.04 (-6.78%)

07:17
10/21/19
10/21
07:17
10/21/19
07:17
Recommendations
Boeing analyst commentary  »

Boeing price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

MNTA

Momenta

$14.43

0.3 (2.12%)

07:17
10/21/19
10/21
07:17
10/21/19
07:17
Conference/Events
Momenta management to meet with Piper Jaffray »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 31

    Oct

  • 07

    Dec

HSIC

Henry Schein

$62.79

-0.72 (-1.13%)

07:16
10/21/19
10/21
07:16
10/21/19
07:16
Hot Stocks
Henry Schein to be dismissed from Summit County opioid litigation »

Henry Schein announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Nov

  • 12

    Dec

MYGN

Myriad Genetics

$30.56

0.24 (0.79%)

07:16
10/21/19
10/21
07:16
10/21/19
07:16
Hot Stocks
Myriad Genetics appoints Mark Pollack as CMO of Myriad Neuroscience »

Myriad Genetics announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

  • 13

    Nov

ATGE

Adtalem Global Education

$35.89

-0.37 (-1.02%)

07:16
10/21/19
10/21
07:16
10/21/19
07:16
Hot Stocks
Adtalem Global Education to sell Adtalem Educacional do Brasil to YDUQS »

Adtalem Global Education…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

  • 13

    Nov

  • 14

    Nov

NVR

NVR

$3,890.80

121.94 (3.24%)

07:16
10/21/19
10/21
07:16
10/21/19
07:16
Recommendations
NVR analyst commentary  »

NVR price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EOG

EOG Resources

$64.47

-2.25 (-3.37%)

07:15
10/21/19
10/21
07:15
10/21/19
07:15
Downgrade
EOG Resources rating change  »

EOG Resources downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Nov

VZ

Verizon

$61.05

0.64 (1.06%)

07:13
10/21/19
10/21
07:13
10/21/19
07:13
Hot Stocks
Verizon to deploy 5G home internet in Chicago »

Starting October 24,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 25

    Oct

  • 26

    Oct

  • 19

    Nov

  • 09

    Dec

PEP

PepsiCo

$136.25

-0.74 (-0.54%)

, KDP

Keurig Dr Pepper

$27.58

-0.01 (-0.04%)

07:12
10/21/19
10/21
07:12
10/21/19
07:12
Recommendations
PepsiCo, Keurig Dr Pepper analyst commentary  »

Morgan Stanley suggests…

PEP

PepsiCo

$136.25

-0.74 (-0.54%)

KDP

Keurig Dr Pepper

$27.58

-0.01 (-0.04%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Nov

LNDC

Landec

$9.41

0.14 (1.51%)

07:11
10/21/19
10/21
07:11
10/21/19
07:11
Conference/Events
Landec management to meet with Maxim »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 28

    Oct

  • 13

    Nov

  • 14

    Nov

  • 15

    Nov

LAC

Lithium Americas

$3.02

0.04 (1.34%)

07:09
10/21/19
10/21
07:09
10/21/19
07:09
Hot Stocks
Lithium Americas appoints Yuan Gao to board of directors »

Lithium Americas…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ARQL

ArQule

$9.13

-0.17 (-1.83%)

07:08
10/21/19
10/21
07:08
10/21/19
07:08
Hot Stocks
ArQule announces preclinical data showing potential for miransertib to treat VMs »

ArQule announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Oct

  • 30

    Oct

SON

Sonoco

$58.07

0.85 (1.49%)

07:08
10/21/19
10/21
07:08
10/21/19
07:08
Upgrade
Sonoco rating change  »

Sonoco upgraded to Market…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DIS

Disney

$130.91

-1.46 (-1.10%)

07:08
10/21/19
10/21
07:08
10/21/19
07:08
Conference/Events
Disney management to meet with Oppenheimer »

Luncheon Meeting to be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 24

    Oct

  • 07

    Nov

IDRA

Idera Pharmaceuticals

$2.68

-0.01 (-0.37%)

07:07
10/21/19
10/21
07:07
10/21/19
07:07
Hot Stocks
Idera Pharmaceuticals annnounces U.S. patent for tilsotolimod »

Idera Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BBI

Brickell Biotech

$4.10

-0.08 (-1.91%)

07:06
10/21/19
10/21
07:06
10/21/19
07:06
Conference/Events
Brickell Biotech management to meet with William Blair »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

SEAS

SeaWorld

$27.88

0.23 (0.83%)

07:06
10/21/19
10/21
07:06
10/21/19
07:06
Hot Stocks
SeaWorld to open second Sesame Place theme park in San Diego in 2021 »

SeaWorld and Sesame…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ARMP

Armata Pharmaceuticals

$4.10

0.05 (1.23%)

07:06
10/21/19
10/21
07:06
10/21/19
07:06
Hot Stocks
Armata Pharmaceuticals announces receipt of $1.3M R&D Tax Incentive »

Armata Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AGTC

Applied Genetic

$3.05

-0.06 (-1.93%)

07:06
10/21/19
10/21
07:06
10/21/19
07:06
Hot Stocks
Applied Genetic presents data from non-clinical studies evaluating AAV vectors »

Applied Genetic…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.